Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis,Therapeutic Advances in Endocrinology and Metabolism

当前位置： X-MOL 学术 › Ther. Adva. Endocrinol. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis
Therapeutic Advances in Endocrinology and Metabolism ( IF 3.8 ) Pub Date : 2022-12-10 , DOI: 10.1177/20420188221142450
Bangjiaxin Ren _{1,

2} , Ming Chen _{2,

3}

Affiliation

Background:Sodium-glucose cotransporter-2 (SGLT2) inhibitors are novel, hypoglycemic drugs exhibiting cardiovascular protective activities. If SGLT2 inhibitors can be successfully used as antihyper...

中文翻译：